An innovative method for determining lipemia interference in blood specimens

Clinica Chimica Acta

Volumn 412, Issue 7-8, 2011, Pages 665-667

  Rosenthal, Murray A ^a   Katz, Hyman B ^a  

^a Alfa Wassermann Diagnostic Technologies   (United States)

Author keywords

HDL; Interference; Intralipid; Lipemia; Triglycerides; Ultracentrifugation

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANALYZER; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; PRIORITY JOURNAL; PRODUCT RECOVERY;

CHOLESTEROL, HDL; HUMANS; HYPERLIPIDEMIAS; TRIGLYCERIDES;

EID: 79551475788     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.11.025     Document Type: Article

References (8)

1. Kroll M.H., Elin R.J. Interference with clinical laboratory analyses. Clin Chem 1994, 40:1996-2005.
2. Sonntag O., Glick M.R. Serum-Index und Interferogramm-Ein neuer Weg zur Prufung und Darstellung von Interferenzen durch Serumchromogene. Lab Med 1989, 13:77-82.
3. Moriyama M., Hayashi N., Ohyabu C., Mukai M., Kawano S., Kumagai S. Performance evaluation and cross-reactivity from insulin analogs with the ARCHITECT Insulin Assay. Clin Chem 2006, 52:1423-1426.
4. Takada K., Nasu H., Hibi N., et al. Serum concentrations of free ubiquitin and multiubiquitin chains. Clin Chem 1997, 43:1188-1195.
5. Ferezou J., Gulik A., Domingo N., et al. Intralipid 10%: physicochemical characterization. Nutrition 2001, 17:930-933.
6. Bornhorst J.A., Roberts R.F., Roberts W.L. Assay-specific differences in lipemic interference in native and Intralipid-supplemented samples. Clin Chem 2004, 50:2197-2201.
7. Jabbar J., Siddiqui I., Raza S.Q., Baig A. To compare the total cholesterol and HDL-cholesterol before and after ultra-centrifugation in lipemic samples. J Pak Med Assoc 2005, 55:239-242.
8. Miyada D., Tipper P., Jantsch D., Simpkins H., Steele W., Flores O. The effect of hyperlipidemia on Technicon SMAC measurements. Clin Biochem 1982, 15:185-188.